tesamorelin

the T torch

overview

What is Tesamorelin?

The Basics: Tesamorelin is a synthetic peptide designed to mimic a naturally occurring hormone in your brain called Growth Hormone-Releasing Hormone (GHRH). Its primary job is to tell your pituitary gland to produce and release more of your body's own natural Growth Hormone (GH).

The Technical Science:

  • Amino Acid Structure: Tesamorelin consists of a 44-amino-acid chain. It is nearly identical to natural GHRH but with one major tweak: a trans-3-hexenoic acid group has been added to the N-terminal (the beginning of the chain).

  • Why the tweak? This modification protects the peptide from being rapidly broken down by enzymes in the blood (specifically DPP-IV). This greatly extends its half-life, making it stay active in the body much longer than natural GHRH.

  • Mechanism of Action: By binding to GHRH receptors on the pituitary gland, it stimulates GH secretion. This newly released GH travels to the liver, where it triggers the production of IGF-1 (Insulin-like Growth Factor-1). Together, GH and IGF-1 break down stubborn body fat and support muscle retention.

  • FDA Approval: It is officially approved (under the brand name Egrifta) to treat HIV-associated lipodystrophy—a condition that causes severe accumulation of visceral adipose tissue (hard belly fat surrounding the organs).

Clinical Efficacy

Tesamorelin is highly effective at targeting Visceral Adipose Tissue (VAT). It does not drastically reduce normal "subcutaneous" fat (the soft fat right under the skin), but it aggressively shrinks the hard, dangerous fat surrounding the internal organs. Clinical trials show an average 15% to 18% reduction in VAT over 26 weeks. This is why it is called the 'T torch' or the 'visceral vanisher.'

Disclaimer: This information is for educational purposes only.